Personalized immune cell therapy for advanced lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a personalized treatment using your own immune cells (called TILs) to fight advanced non-small cell lung cancer that has progressed after standard therapy. You would have surgery to collect a tumor sample, then receive your expanded immune cells back as an infusion.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced non-small cell lung cancer that has gotten worse after at least one standard treatment
- You are 18 years or older and willing to have surgery to remove a piece of your tumor
- You are in generally good health (able to do daily activities without major assistance)
- Your cancer has not spread to the brain, or if it has, it has been treated and stable for at least a month
- You do not have another active cancer, serious infections, or autoimmune diseases requiring treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental cell therapy (GC101) for people with advanced non-small cell lung cancer. It uses your own tumor-fighting immune cells, called TILs, grown in a lab and given back to you. The goal is to see if it can shrink tumors or slow the disease.
This trial tests a treatment using your own immune cells (called TILs) to fight multiple early-stage lung cancers. The cells are collected from a tumor sample, grown in a lab, and given back to you to help your body attack the cancer.
This trial tests a new cell therapy that uses your own immune cells (TILs) to fight lung cancer. If you have advanced non-small cell lung cancer and standard treatments haven't worked, this treatment might help your immune system attack the cancer more effectively.
This trial tests a new treatment using your own immune cells (called TILs) to fight advanced non-small cell lung cancer. The cells are taken from a tumor, multiplied in a lab, and given back to you to help your body attack the cancer.
This trial tests a new treatment for advanced non-small cell lung cancer that has stopped responding to a targeted pill (EGFR-TKI). It combines your own immune cells, grown in a lab, with another targeted pill to try to fight the cancer.
This trial is testing a personalized treatment for non-small cell lung cancer that uses a patient's own immune cells to fight the tumor. It may help patients with early or advanced stages of the disease.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.